297 related articles for article (PubMed ID: 32406490)
21. Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies.
Costa D; Capuano M; Sommese L; Napoli C
Blood Cells Mol Dis; 2015 Aug; 55(2):95-100. PubMed ID: 26142322
[TBL] [Abstract][Full Text] [Related]
22. Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β
Cosenza LC; Zuccato C; Zurlo M; Gambari R; Finotti A
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292612
[TBL] [Abstract][Full Text] [Related]
23. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Métais JY; Doerfler PA; Mayuranathan T; Bauer DE; Fowler SC; Hsieh MM; Katta V; Keriwala S; Lazzarotto CR; Luk K; Neel MD; Perry SS; Peters ST; Porter SN; Ryu BY; Sharma A; Shea D; Tisdale JF; Uchida N; Wolfe SA; Woodard KJ; Wu Y; Yao Y; Zeng J; Pruett-Miller S; Tsai SQ; Weiss MJ
Blood Adv; 2019 Nov; 3(21):3379-3392. PubMed ID: 31698466
[TBL] [Abstract][Full Text] [Related]
24. Combined approaches for increasing fetal hemoglobin (HbF) and
Finotti A; Gambari R
Front Genome Ed; 2023; 5():1204536. PubMed ID: 37529398
[TBL] [Abstract][Full Text] [Related]
25. Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.
Ghiaccio V; Chappell M; Rivella S; Breda L
Mol Diagn Ther; 2019 Apr; 23(2):173-186. PubMed ID: 30701409
[TBL] [Abstract][Full Text] [Related]
26. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.
Psatha N; Georgakopoulou A; Li C; Nandakumar V; Georgolopoulos G; Acosta R; Paschoudi K; Nelson J; Chee D; Athanasiadou A; Kouvatsi A; Funnell APW; Lieber A; Yannaki E; Papayannopoulou T
Blood; 2021 Oct; 138(17):1540-1553. PubMed ID: 34086867
[TBL] [Abstract][Full Text] [Related]
27. KLF1 drives the expression of fetal hemoglobin in British HPFH.
Wienert B; Martyn GE; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
Blood; 2017 Aug; 130(6):803-807. PubMed ID: 28659276
[TBL] [Abstract][Full Text] [Related]
28. Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.
Venkatesan V; Christopher AC; Rhiel M; Azhagiri MKK; Babu P; Walavalkar K; Saravanan B; Andrieux G; Rangaraj S; Srinivasan S; Karuppusamy KV; Jacob A; Bagchi A; Pai AA; Nakamura Y; Kurita R; Balasubramanian P; Pai R; Marepally SK; Mohankumar KM; Velayudhan SR; Boerries M; Notani D; Cathomen T; Srivastava A; Thangavel S
Mol Ther Nucleic Acids; 2023 Jun; 32():671-688. PubMed ID: 37215154
[TBL] [Abstract][Full Text] [Related]
29. 3'HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression.
Himadewi P; Wang XQD; Feng F; Gore H; Liu Y; Yu L; Kurita R; Nakamura Y; Pfeifer GP; Liu J; Zhang X
Elife; 2021 Sep; 10():. PubMed ID: 34585664
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
[TBL] [Abstract][Full Text] [Related]
31. Induction of therapeutic levels of HbF in genome-edited primary β
Mingoia M; Caria CA; Ye L; Asunis I; Marongiu MF; Manunza L; Sollaino MC; Wang J; Cabriolu A; Kurita R; Nakamura Y; Cucca F; Kan YW; Marini MG; Moi P
Br J Haematol; 2021 Jan; 192(2):395-404. PubMed ID: 33216968
[TBL] [Abstract][Full Text] [Related]
32. Insight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets.
Hariharan P; Nadkarni A
Blood Rev; 2021 Sep; 49():100823. PubMed ID: 33726930
[TBL] [Abstract][Full Text] [Related]
33. Multiplex ligation-dependent probe amplification screening of isolated increased HbF levels revealed three cases of novel rearrangements/deletions in the beta-globin gene cluster.
Lee ST; Yoo EH; Kim JY; Kim JW; Ki CS
Br J Haematol; 2010 Jan; 148(1):154-60. PubMed ID: 19807730
[TBL] [Abstract][Full Text] [Related]
34. A unified model of human hemoglobin switching through single-cell genome editing.
Shen Y; Verboon JM; Zhang Y; Liu N; Kim YJ; Marglous S; Nandakumar SK; Voit RA; Fiorini C; Ejaz A; Basak A; Orkin SH; Xu J; Sankaran VG
Nat Commun; 2021 Aug; 12(1):4991. PubMed ID: 34404810
[TBL] [Abstract][Full Text] [Related]
35. Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes.
Steinberg MH
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238542
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression.
Han Y; Tan X; Jin T; Zhao S; Hu L; Zhang W; Kurita R; Nakamura Y; Liu J; Li D; Zhang Z; Fang X; Huang S
Eur J Pharmacol; 2022 Mar; 918():174788. PubMed ID: 35093321
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of hereditary persistence of fetal hemoglobin.
Forget BG
Ann N Y Acad Sci; 1998 Jun; 850():38-44. PubMed ID: 9668525
[TBL] [Abstract][Full Text] [Related]
38. Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults.
Jouini L; Bibi A; Ouali F; Hadj Fredj S; Ouennich F; Siala H; Messaoud T; Fattoum S
Mol Biol Rep; 2012 Apr; 39(4):4619-25. PubMed ID: 21947948
[TBL] [Abstract][Full Text] [Related]
39. Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia.
Lu D; Xu Z; Peng Z; Yang Y; Song B; Xiong Z; Ma Z; Guan H; Chen B; Nakamura Y; Zeng J; Liu N; Sun X; Chen D
Front Genet; 2022; 13():881937. PubMed ID: 35656314
[TBL] [Abstract][Full Text] [Related]
40. A natural regulatory mutation in the proximal promoter elevates fetal
Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
